1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Serotonin Antagonists 1.2.3 Steroids 1.2.4 Dopamine Antagonists 1.2.5 NK-1 Receptor Antagonists 1.2.6 Non-pharmacologic Treatment 1.2.7 Others 1.3 Market by Application 1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2017-2028) 2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region 2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2017-2022) 2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2028) 2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics 2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends 2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers 2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges 2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue 3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2017-2022) 3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2017-2022) 3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue 3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio 3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2021 3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served 3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service 3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type 4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2017-2022) 4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2028) 5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application 5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2017-2022) 5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028) 6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) 6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028) 7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) 7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028) 8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) 8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028) 9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) 9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028) 10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) 10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Acacia Pharma 11.1.1 Acacia Pharma Company Detail 11.1.2 Acacia Pharma Business Overview 11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction 11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.1.5 Acacia Pharma Recent Development 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Company Detail 11.2.2 F. Hoffmann-La Roche Business Overview 11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction 11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.2.5 F. Hoffmann-La Roche Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction 11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.3.5 Novartis Recent Development 11.4 Ani Pharmaceuticals 11.4.1 Ani Pharmaceuticals Company Detail 11.4.2 Ani Pharmaceuticals Business Overview 11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction 11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.4.5 Ani Pharmaceuticals Recent Development 11.5 Camurus 11.5.1 Camurus Company Detail 11.5.2 Camurus Business Overview 11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction 11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.5.5 Camurus Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Detail 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction 11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.6.5 Sanofi Recent Development 11.7 Helsinn Holding 11.7.1 Helsinn Holding Company Detail 11.7.2 Helsinn Holding Business Overview 11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction 11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.7.5 Helsinn Holding Recent Development 11.8 Eisai 11.8.1 Eisai Company Detail 11.8.2 Eisai Business Overview 11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction 11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.8.5 Eisai Recent Development 11.9 Merck 11.9.1 Merck Company Detail 11.9.2 Merck Business Overview 11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction 11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.9.5 Merck Recent Development 11.10 GlaxoSmithKline 11.10.1 GlaxoSmithKline Company Detail 11.10.2 GlaxoSmithKline Business Overview 11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction 11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) 11.10.5 GlaxoSmithKline Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Serotonin Antagonists Table 3. Key Players of Steroids Table 4. Key Players of Dopamine Antagonists Table 5. Key Players of NK-1 Receptor Antagonists Table 6. Key Players of Non-pharmacologic Treatment Table 7. Key Players of Others Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2017-2022) Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2023-2028) Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2017-2022) Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2021) Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2017-2022) Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2023-2028) Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2017-2022) Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2023-2028) Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million) Table 45. Acacia Pharma Company Detail Table 46. Acacia Pharma Business Overview Table 47. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Table 48. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 49. Acacia Pharma Recent Development Table 50. F. Hoffmann-La Roche Company Detail Table 51. F. Hoffmann-La Roche Business Overview Table 52. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Table 53. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 54. F. Hoffmann-La Roche Recent Development Table 55. Novartis Company Detail Table 56. Novartis Business Overview Table 57. Novartis Postoperative Nausea and Vomiting (PONV) Product Table 58. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 59. Novartis Recent Development Table 60. Ani Pharmaceuticals Company Detail Table 61. Ani Pharmaceuticals Business Overview Table 62. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Table 63. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 64. Ani Pharmaceuticals Recent Development Table 65. Camurus Company Detail Table 66. Camurus Business Overview Table 67. Camurus Postoperative Nausea and Vomiting (PONV) Product Table 68. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 69. Camurus Recent Development Table 70. Sanofi Company Detail Table 71. Sanofi Business Overview Table 72. Sanofi Postoperative Nausea and Vomiting (PONV) Product Table 73. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 74. Sanofi Recent Development Table 75. Helsinn Holding Company Detail Table 76. Helsinn Holding Business Overview Table 77. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Table 78. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 79. Helsinn Holding Recent Development Table 80. Eisai Company Detail Table 81. Eisai Business Overview Table 82. Eisai Postoperative Nausea and Vomiting (PONV) Product Table 83. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 84. Eisai Recent Development Table 85. Merck Company Detail Table 86. Merck Business Overview Table 87. Merck Postoperative Nausea and Vomiting (PONV) Product Table 88. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 89. Merck Recent Development Table 90. GlaxoSmithKline Company Detail Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Table 93. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Table 94. GlaxoSmithKline Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2021 VS 2028 Figure 2. Serotonin Antagonists Features Figure 3. Steroids Features Figure 4. Dopamine Antagonists Features Figure 5. NK-1 Receptor Antagonists Features Figure 6. Non-pharmacologic Treatment Features Figure 7. Others Features Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application in 2021 & 2028 Figure 9. Hospital Pharmacies Case Studies Figure 10. Online Pharmacies Case Studies Figure 11. Retail Pharmacies Case Studies Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region: 2021 VS 2028 Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2021 Figure 17. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2021 Figure 19. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2017-2028) Figure 21. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2017-2028) Figure 25. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2017-2028) Figure 33. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2017-2028) Figure 41. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2017-2028) Figure 45. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 49. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 50. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 51. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 52. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 53. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 54. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 55. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 56. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Acacia Pharma F. Hoffmann-La Roche Novartis Ani Pharmaceuticals Camurus Sanofi Helsinn Holding Eisai Merck GlaxoSmithKline